Axogen, Inc. · NASDAQ
Zacks Investment Research
AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings GrowthSign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about AXGN?
Zacks Investment Research
GMED or AXGN: Which Is the Better Value Stock Right Now?In a comparison of two medical instruments stocks, Globus Medical (GMED) and AxoGen (AXGN), both holding a Zacks Rank #2 (Buy), GMED emerges as the superior value option. GMED has a forward P/E of 15.81 compared to AXGN's 73.46, a PEG ratio of 1.27 vs 1.42, and a P/B ratio of 2.22 vs 7.47, earning GMED a Value grade of B while AXGN received an F.
Zacks Investment Research
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)AxoGen (AXGN) has declined 22.6% over four weeks and is now in oversold territory with an RSI reading of 27.04, suggesting a potential reversal. Wall Street analysts have raised earnings estimates by 2.2% over the past 30 days, and the stock holds a Zacks Rank #2 (Buy) rating, indicating potential for near-term price appreciation.
Headlines link to the publisher. Not investment advice.
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $AXGN
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
